Rxology Labs Inc. Investor Relations

 

Building a Safer, Cleaner Standard for Medication Waste

Rxology Labs Inc. is a Canadian healthcare innovation company focused on simplifying medication waste disposal at the point of care. Our flagship product, Drug Destructor, is a bedside medication waste bag designed for hospitals, surgical suites, clinics, and other care environments where excess or unused medication must be disposed of safely, quickly, and efficiently.

Medication waste is a persistent operational challenge in healthcare. In high-acuity settings such as operating rooms, emergency departments, intensive care units, and procedural areas, medication waste is generated daily. Traditional disposal workflows can be inefficient, inconsistent, and dependent on staff leaving the point of care to dispose of residual medication. These gaps create unnecessary workflow burden, potential diversion risk, environmental concern, and avoidable complexity for hospitals.

Drug Destructor was created to address this problem with a simple, practical, and scalable solution.

 

Investor Inquiries

Rxology Labs welcomes conversations with investors, strategic partners, distributors, and healthcare organizations aligned with our mission.

For investor relations inquiries, please contact:

Rxology Labs Inc.
Email: contact@drugdestructor.com
Website: www.drugdestructor.com

 

The Opportunity

Hospitals and clinics are under growing pressure to improve medication safety, reduce environmental impact, prevent diversion, and streamline clinical workflows. Medication waste management sits at the intersection of all four.

Drug Destructor provides a ready-to-use bedside solution that allows healthcare staff to dispose of solid and liquid medication waste immediately where medications are administered. The product is designed to be simple to implement, low cost, and suitable for acute care environments.

Rxology Labs is focused on becoming a trusted Canadian leader in point-of-care medication waste solutions, with an initial focus on hospitals, operating rooms, anesthesia departments, critical care, and procedural areas.

Our Product: Drug Destructor

Drug Destructor bags are bedside medication waste bags designed to simplify the disposal of excess medication at the point of care.

Each bag contains an absorbent sachet that helps render medication waste unusable, supporting safer medication handling and helping reduce the risk of diversion. The bags are suitable for both solid and liquid medication waste and are designed for fast adoption without expensive capital equipment or complicated workflow redesign.

Key Product Advantages

• Point-of-care medication waste disposal
• Suitable for solid and liquid medication waste
• Simple to use and easy to implement
• No expensive capital investment required
• Supports diversion prevention strategies
• Helps keep staff and patients safe
• Appropriate for acute care, critical care, anesthesia, and procedural settings
• Latex free and DEHP free
• Compact, ready-to-use format

Drug Destructor is intentionally practical: a low-barrier product that solves a real clinical workflow problem.

Why Hospitals Need This

Medication waste disposal is not just a back-end environmental issue. It is a frontline clinical workflow issue.

In many hospital settings, residual medication remains in syringes, vials, cups, or containers until staff are able to complete a disposal process. This can create avoidable risk and inefficiency. Drug Destructor allows medication waste to be handled immediately at the bedside or point of care.

For hospitals, this creates value across multiple priorities:

Medication Safety

Supports safer disposal practices and reduces opportunities for medication to remain accessible after use.

Diversion Prevention

Provides a practical point-of-care process to help reduce the risk of unused or excess medication being diverted.

Workflow Efficiency

Allows nurses, anesthesiologists, and other clinicians to dispose of medication waste where care is delivered.

Environmental Responsibility

Supports responsible medication waste management and helps prevent pharmaceutical waste from entering water systems.

Cost-Effective Implementation

Requires no major infrastructure, capital equipment, or complex installation.

Environmental Commitment

Rxology Labs was founded with a commitment to reducing the environmental impact of healthcare.

Drug Destructor is designed with attention to material use, sourcing, and responsible waste management. Our environmental priorities include:

• Keeping medication waste out of waterways
• Using activated carbon sourced from recycled coconut husk waste
• Reducing plastic use compared with alternative products where possible
• Supporting lean sourcing and efficient logistics
• Operating from a centrally located Canadian warehouse to reduce unnecessary reshipping
• Supporting carbon offset efforts through tree planting initiatives

Healthcare needs practical environmental solutions that work in real clinical settings. Drug Destructor is designed to help hospitals improve medication waste practices without creating unnecessary operational burden.

Market Focus

Rxology Labs is initially focused on the Canadian hospital market, with particular emphasis on:

• Operating rooms
• Anesthesia departments
• Emergency departments
• Intensive care units
• Procedural suites
• Acute care nursing units
• Hospital pharmacies
• Outpatient clinics and surgical centres

Our primary customer is the hospital or health authority seeking a practical, scalable, and cost-effective approach to medication waste disposal at the point of care.

Drug Destructor is especially well positioned for areas where medication waste is frequent, controlled substances are handled, and workflow simplicity is essential.

Commercial Strategy

Rxology Labs is pursuing a focused commercialization strategy built around direct engagement with hospital decision-makers, pharmacy leaders, anesthesia departments, and clinical champions.

Our growth model includes:

1. Targeted hospital pilots
   Providing samples and limited trials to demonstrate usability, workflow fit, and frontline acceptance.
2. Clinical champion adoption
   Working with anesthesiologists, pharmacists, nurses, and medication safety leaders who understand the need for better point-of-care disposal.
3. Health authority and hospital system expansion
   Building from individual department adoption toward site-wide or regional purchasing.
4. Low-friction procurement
   Offering a simple consumable product with no capital equipment requirement and straightforward implementation.
5. Canadian-first positioning
   Emphasizing that Rxology Labs is a Canadian company solving a practical healthcare problem for Canadian hospitals but also globally.

Investment Thesis

Rxology Labs offers investors exposure to a focused healthcare product company addressing a clear operational need in medication safety, diversion prevention, and environmental stewardship.

Why Rxology Labs

• Real clinical problem with clear hospital use case
• Simple product with low implementation burden
• Consumable model with recurring purchase potential
• Strong fit with hospital safety, pharmacy, anesthesia, and sustainability priorities
• Canadian-owned healthcare innovation company
• Opportunity for expansion across hospitals, clinics, procedural areas, and international markets
• Product positioned at the intersection of medication safety, workflow efficiency, diversion prevention, and environmental responsibility

Drug Destructor is not a theoretical technology looking for a problem. It is a practical solution built for a known healthcare workflow challenge.

Growth Priorities

Rxology Labs is focused on disciplined growth in the following areas:

Canadian Hospital Expansion

Increasing adoption across Canadian hospitals, with an initial focus on operating rooms, anesthesia departments, and acute care settings.

Health Authority Partnerships

Building relationships with pharmacy, clinical operations, anesthesia, medication safety, and sustainability leaders.

Product Line Development

Exploring additional medication waste and healthcare sustainability products that align with the Rxology Labs mission.

Operational Scale

Strengthening supply chain, warehousing, distribution, and procurement processes to support larger institutional customers.

Environmental Leadership

Continuing to improve product design, sourcing, and sustainability practices as the company scales.

Founder-Led Healthcare Innovation

Rxology Labs was founded by healthcare professionals with firsthand understanding of medication systems, hospital operations, and the realities of frontline clinical care.

This direct healthcare experience shapes the company’s approach: build products that are simple, useful, safe, and easy for hospitals to adopt.

Our goal is not to add complexity to healthcare. Our goal is to remove it.

Forward-Looking Information

This page may contain forward-looking statements regarding Rxology Labs Inc., its business plans, market opportunities, growth strategy, and product development priorities. Forward-looking statements are based on current expectations and assumptions and are subject to risks and uncertainties. Actual results may differ materially from those expressed or implied. Nothing on this page should be interpreted as an offer to sell securities or a solicitation of an offer to buy securities.